Pages that link to "Q83920798"
Jump to navigation
Jump to search
The following pages link to Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials (Q83920798):
Displaying 13 items.
- Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review (Q26743786) (← links)
- Targeted Treatment in Childhood Epilepsy Syndromes (Q26751431) (← links)
- K( ) channelepsy: progress in the neurobiology of potassium channels and epilepsy (Q30449041) (← links)
- Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany. (Q35909508) (← links)
- Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy (Q36144410) (← links)
- European Survey of Prescriber Understanding of Risks Associated with Retigabine (Q38398245) (← links)
- Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy (Q38407322) (← links)
- Validation of ion channel targets (Q38630110) (← links)
- Physician and Pharmacist Understanding of the Risk of Urinary Retention with Retigabine (Ezogabine): A REMS Assessment Survey (Q38675337) (← links)
- Efficacy of Retigabine on Acute Limbic Seizures in Adult Rats (Q41942478) (← links)
- Update on novel targets and potential treatment avenues in pulmonary hypertension (Q42784219) (← links)
- A review of the pharmacology and clinical efficacy of brivaracetam (Q49700507) (← links)
- Antiepileptic drugs in development pipeline: A recent update (Q49882750) (← links)